{"data":[{"accessionNo":"0001172661-26-003482","formType":"SCHEDULE 13G/A","amendmentNo":2,"issuerCik":"0001776111","issuerName":"MBX Biosciences, Inc.","ticker":"MBX","cusip":"55287L101","securityClass":"Common Stock, $0.0001 par value per share","eventDate":"2026-06-30","reportingPerson":"David Kroin","reportingCik":null,"personType":"HC,IN","sharesOwned":1732569,"percentOfClass":3.64,"filedAt":"2026-08-14","canonicalUrl":"https://xoomar.com/markets/stocks/mbx"},{"accessionNo":"0001172661-26-003482","formType":"SCHEDULE 13G/A","amendmentNo":2,"issuerCik":"0001776111","issuerName":"MBX Biosciences, Inc.","ticker":"MBX","cusip":"55287L101","securityClass":"Common Stock, $0.0001 par value per share","eventDate":"2026-06-30","reportingPerson":"Deep Track Capital, LP","reportingCik":null,"personType":"IA,OO","sharesOwned":1732569,"percentOfClass":3.64,"filedAt":"2026-08-14","canonicalUrl":"https://xoomar.com/markets/stocks/mbx"},{"accessionNo":"0001172661-26-003482","formType":"SCHEDULE 13G/A","amendmentNo":2,"issuerCik":"0001776111","issuerName":"MBX Biosciences, Inc.","ticker":"MBX","cusip":"55287L101","securityClass":"Common Stock, $0.0001 par value per share","eventDate":"2026-06-30","reportingPerson":"Deep Track Biotechnology Master Fund, Ltd.","reportingCik":null,"personType":"CO","sharesOwned":1732569,"percentOfClass":3.64,"filedAt":"2026-08-14","canonicalUrl":"https://xoomar.com/markets/stocks/mbx"},{"accessionNo":"0001231919-26-000851","formType":"SCHEDULE 13D/A","amendmentNo":3,"issuerCik":"0001776111","issuerName":"MBX BIOSCIENCES, INC.","ticker":"MBX","cusip":"55287L101","securityClass":"Common Stock, $0.0001 par value per share","eventDate":"2026-08-06","reportingPerson":"Patrick J. Heron","reportingCik":"0001365617","personType":"IN","sharesOwned":5243421,"percentOfClass":11.7,"filedAt":"2026-08-10","canonicalUrl":"https://xoomar.com/markets/stocks/mbx"},{"accessionNo":"0001231919-26-000851","formType":"SCHEDULE 13D/A","amendmentNo":3,"issuerCik":"0001776111","issuerName":"MBX BIOSCIENCES, INC.","ticker":"MBX","cusip":"55287L101","securityClass":"Common Stock, $0.0001 par value per share","eventDate":"2026-08-06","reportingPerson":"James N. Topper","reportingCik":"0001341382","personType":"IN","sharesOwned":5219440,"percentOfClass":11.7,"filedAt":"2026-08-10","canonicalUrl":"https://xoomar.com/markets/stocks/mbx"},{"accessionNo":"0001231919-26-000851","formType":"SCHEDULE 13D/A","amendmentNo":3,"issuerCik":"0001776111","issuerName":"MBX BIOSCIENCES, INC.","ticker":"MBX","cusip":"55287L101","securityClass":"Common Stock, $0.0001 par value per share","eventDate":"2026-08-06","reportingPerson":"FHMLS X, L.L.C.","reportingCik":"0001790811","personType":"OO","sharesOwned":5219440,"percentOfClass":10.8,"filedAt":"2026-08-10","canonicalUrl":"https://xoomar.com/markets/stocks/mbx"},{"accessionNo":"0001231919-26-000851","formType":"SCHEDULE 13D/A","amendmentNo":3,"issuerCik":"0001776111","issuerName":"MBX BIOSCIENCES, INC.","ticker":"MBX","cusip":"55287L101","securityClass":"Common Stock, $0.0001 par value per share","eventDate":"2026-08-06","reportingPerson":"Frazier Life Sciences X, L.P.","reportingCik":"0001790879","personType":"PN","sharesOwned":5219440,"percentOfClass":10.8,"filedAt":"2026-08-10","canonicalUrl":"https://xoomar.com/markets/stocks/mbx"},{"accessionNo":"0001231919-26-000851","formType":"SCHEDULE 13D/A","amendmentNo":3,"issuerCik":"0001776111","issuerName":"MBX BIOSCIENCES, INC.","ticker":"MBX","cusip":"55287L101","securityClass":"Common Stock, $0.0001 par value per share","eventDate":"2026-08-06","reportingPerson":"FHMLS X, L.P.","reportingCik":"0001790880","personType":"PN","sharesOwned":5219440,"percentOfClass":10.8,"filedAt":"2026-08-10","canonicalUrl":"https://xoomar.com/markets/stocks/mbx"},{"accessionNo":"0000947871-26-000776","formType":"SCHEDULE 13D/A","amendmentNo":3,"issuerCik":"0001776111","issuerName":"MBX Biosciences, Inc.","ticker":"MBX","cusip":"55287L101","securityClass":"COMMON STOCK","eventDate":"2026-08-06","reportingPerson":"ORBIMED ADVISORS LLC","reportingCik":"0001055951","personType":"IA","sharesOwned":3074853,"percentOfClass":6.4,"filedAt":"2026-08-10","canonicalUrl":"https://xoomar.com/markets/stocks/mbx"},{"accessionNo":"0000947871-26-000776","formType":"SCHEDULE 13D/A","amendmentNo":3,"issuerCik":"0001776111","issuerName":"MBX Biosciences, Inc.","ticker":"MBX","cusip":"55287L101","securityClass":"COMMON STOCK","eventDate":"2026-08-06","reportingPerson":"ORBIMED CAPITAL GP VII LLC","reportingCik":"0001760648","personType":"OO","sharesOwned":2505150,"percentOfClass":5.2,"filedAt":"2026-08-10","canonicalUrl":"https://xoomar.com/markets/stocks/mbx"},{"accessionNo":"0001231919-26-000851","formType":"SCHEDULE 13D/A","amendmentNo":3,"issuerCik":"0001776111","issuerName":"MBX BIOSCIENCES, INC.","ticker":"MBX","cusip":"55287L101","securityClass":"Common Stock, $0.0001 par value per share","eventDate":"2026-08-06","reportingPerson":"FHMLSP, L.L.C.","reportingCik":"0001879465","personType":"OO","sharesOwned":1429573,"percentOfClass":3,"filedAt":"2026-08-10","canonicalUrl":"https://xoomar.com/markets/stocks/mbx"},{"accessionNo":"0001231919-26-000851","formType":"SCHEDULE 13D/A","amendmentNo":3,"issuerCik":"0001776111","issuerName":"MBX BIOSCIENCES, INC.","ticker":"MBX","cusip":"55287L101","securityClass":"Common Stock, $0.0001 par value per share","eventDate":"2026-08-06","reportingPerson":"Frazier Life Sciences Public Fund, L.P.","reportingCik":"0001863769","personType":"PN","sharesOwned":1429573,"percentOfClass":3,"filedAt":"2026-08-10","canonicalUrl":"https://xoomar.com/markets/stocks/mbx"},{"accessionNo":"0001231919-26-000851","formType":"SCHEDULE 13D/A","amendmentNo":3,"issuerCik":"0001776111","issuerName":"MBX BIOSCIENCES, INC.","ticker":"MBX","cusip":"55287L101","securityClass":"Common Stock, $0.0001 par value per share","eventDate":"2026-08-06","reportingPerson":"FHMLSP, L.P.","reportingCik":"0001879466","personType":"PN","sharesOwned":1429573,"percentOfClass":3,"filedAt":"2026-08-10","canonicalUrl":"https://xoomar.com/markets/stocks/mbx"},{"accessionNo":"0000947871-26-000776","formType":"SCHEDULE 13D/A","amendmentNo":3,"issuerCik":"0001776111","issuerName":"MBX Biosciences, Inc.","ticker":"MBX","cusip":"55287L101","securityClass":"COMMON STOCK","eventDate":"2026-08-06","reportingPerson":"ORBIMED GENESIS GP LLC","reportingCik":"0001808744","personType":"OO","sharesOwned":569703,"percentOfClass":1.2,"filedAt":"2026-08-10","canonicalUrl":"https://xoomar.com/markets/stocks/mbx"},{"accessionNo":"0001231919-26-000851","formType":"SCHEDULE 13D/A","amendmentNo":3,"issuerCik":"0001776111","issuerName":"MBX BIOSCIENCES, INC.","ticker":"MBX","cusip":"55287L101","securityClass":"Common Stock, $0.0001 par value per share","eventDate":"2026-08-06","reportingPerson":"FHMLS XI, L.L.C.","reportingCik":"0001911623","personType":"OO","sharesOwned":3000,"percentOfClass":0,"filedAt":"2026-08-10","canonicalUrl":"https://xoomar.com/markets/stocks/mbx"},{"accessionNo":"0001231919-26-000851","formType":"SCHEDULE 13D/A","amendmentNo":3,"issuerCik":"0001776111","issuerName":"MBX BIOSCIENCES, INC.","ticker":"MBX","cusip":"55287L101","securityClass":"Common Stock, $0.0001 par value per share","eventDate":"2026-08-06","reportingPerson":"Frazier Life Sciences XI, L.P.","reportingCik":"0001911592","personType":"PN","sharesOwned":3000,"percentOfClass":0,"filedAt":"2026-08-10","canonicalUrl":"https://xoomar.com/markets/stocks/mbx"},{"accessionNo":"0001231919-26-000851","formType":"SCHEDULE 13D/A","amendmentNo":3,"issuerCik":"0001776111","issuerName":"MBX BIOSCIENCES, INC.","ticker":"MBX","cusip":"55287L101","securityClass":"Common Stock, $0.0001 par value per share","eventDate":"2026-08-06","reportingPerson":"FHMLS XI, L.P.","reportingCik":"0001911580","personType":"PN","sharesOwned":3000,"percentOfClass":0,"filedAt":"2026-08-10","canonicalUrl":"https://xoomar.com/markets/stocks/mbx"},{"accessionNo":"0002012383-26-002818","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001776111","issuerName":"MBX BIOSCIENCES INC","ticker":"MBX","cusip":"55287L101","securityClass":"Common Stock","eventDate":"2026-06-30","reportingPerson":"BlackRock, Inc.","reportingCik":null,"personType":"HC","sharesOwned":2628181,"percentOfClass":5.5,"filedAt":"2026-07-29","canonicalUrl":"https://xoomar.com/markets/stocks/mbx"},{"accessionNo":"0000315066-26-001474","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001776111","issuerName":"MBX BIOSCIENCES INC","ticker":"MBX","cusip":"55287L101","securityClass":"COMMON STOCK","eventDate":"2026-06-30","reportingPerson":"FMR LLC","reportingCik":null,"personType":"HC","sharesOwned":5322884.68,"percentOfClass":11.2,"filedAt":"2026-07-08","canonicalUrl":"https://xoomar.com/markets/stocks/mbx"},{"accessionNo":"0000315066-26-001474","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001776111","issuerName":"MBX BIOSCIENCES INC","ticker":"MBX","cusip":"55287L101","securityClass":"COMMON STOCK","eventDate":"2026-06-30","reportingPerson":"Abigail P. Johnson","reportingCik":null,"personType":"IN","sharesOwned":5322884.68,"percentOfClass":11.2,"filedAt":"2026-07-08","canonicalUrl":"https://xoomar.com/markets/stocks/mbx"},{"accessionNo":"0000902219-26-000214","formType":"SCHEDULE 13G/A","amendmentNo":5,"issuerCik":"0001776111","issuerName":"MBX Biosciences","ticker":"MBX","cusip":"55287L101","securityClass":"Common Stock","eventDate":"2026-06-30","reportingPerson":"Wellington Investment Advisors Holdings LLP","reportingCik":null,"personType":"HC","sharesOwned":4977523,"percentOfClass":10.5,"filedAt":"2026-07-08","canonicalUrl":"https://xoomar.com/markets/stocks/mbx"},{"accessionNo":"0000902219-26-000214","formType":"SCHEDULE 13G/A","amendmentNo":5,"issuerCik":"0001776111","issuerName":"MBX Biosciences","ticker":"MBX","cusip":"55287L101","securityClass":"Common Stock","eventDate":"2026-06-30","reportingPerson":"Wellington Group Holdings LLP","reportingCik":null,"personType":"HC","sharesOwned":4977523,"percentOfClass":10.5,"filedAt":"2026-07-08","canonicalUrl":"https://xoomar.com/markets/stocks/mbx"},{"accessionNo":"0000902219-26-000214","formType":"SCHEDULE 13G/A","amendmentNo":5,"issuerCik":"0001776111","issuerName":"MBX Biosciences","ticker":"MBX","cusip":"55287L101","securityClass":"Common Stock","eventDate":"2026-06-30","reportingPerson":"Wellington Management Group LLP","reportingCik":null,"personType":"HC","sharesOwned":4977523,"percentOfClass":10.5,"filedAt":"2026-07-08","canonicalUrl":"https://xoomar.com/markets/stocks/mbx"},{"accessionNo":"0000902219-26-000214","formType":"SCHEDULE 13G/A","amendmentNo":5,"issuerCik":"0001776111","issuerName":"MBX Biosciences","ticker":"MBX","cusip":"55287L101","securityClass":"Common Stock","eventDate":"2026-06-30","reportingPerson":"Wellington Management Company LLP","reportingCik":null,"personType":"IA","sharesOwned":4977523,"percentOfClass":9.8,"filedAt":"2026-07-08","canonicalUrl":"https://xoomar.com/markets/stocks/mbx"},{"accessionNo":"0001104659-26-077301","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001776111","issuerName":"MBX Biosciences, Inc.","ticker":"MBX","cusip":"55287L101","securityClass":"Common Stock, $0.0001 par value per share","eventDate":"2026-06-16","reportingPerson":"Senai Asefaw, M.D.","reportingCik":null,"personType":"IN","sharesOwned":2493015,"percentOfClass":5.2,"filedAt":"2026-06-24","canonicalUrl":"https://xoomar.com/markets/stocks/mbx"},{"accessionNo":"0001104659-26-077301","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001776111","issuerName":"MBX Biosciences, Inc.","ticker":"MBX","cusip":"55287L101","securityClass":"Common Stock, $0.0001 par value per share","eventDate":"2026-06-16","reportingPerson":"Paradigm BioCapital Advisors GP LLC","reportingCik":null,"personType":"OO","sharesOwned":2493015,"percentOfClass":5.2,"filedAt":"2026-06-24","canonicalUrl":"https://xoomar.com/markets/stocks/mbx"},{"accessionNo":"0001104659-26-077301","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001776111","issuerName":"MBX Biosciences, Inc.","ticker":"MBX","cusip":"55287L101","securityClass":"Common Stock, $0.0001 par value per share","eventDate":"2026-06-16","reportingPerson":"Paradigm BioCapital Advisors LP","reportingCik":null,"personType":"PN","sharesOwned":2493015,"percentOfClass":5.2,"filedAt":"2026-06-24","canonicalUrl":"https://xoomar.com/markets/stocks/mbx"},{"accessionNo":"0001104659-26-077301","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001776111","issuerName":"MBX Biosciences, Inc.","ticker":"MBX","cusip":"55287L101","securityClass":"Common Stock, $0.0001 par value per share","eventDate":"2026-06-16","reportingPerson":"Paradigm BioCapital International Fund Ltd.","reportingCik":null,"personType":"CO","sharesOwned":2187207,"percentOfClass":4.6,"filedAt":"2026-06-24","canonicalUrl":"https://xoomar.com/markets/stocks/mbx"},{"accessionNo":"0000315066-26-001256","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001776111","issuerName":"MBX BIOSCIENCES INC","ticker":"MBX","cusip":"55287L101","securityClass":"COMMON STOCK","eventDate":"2026-03-31","reportingPerson":"Abigail P. Johnson","reportingCik":null,"personType":"IN","sharesOwned":2936684,"percentOfClass":6.2,"filedAt":"2026-05-06","canonicalUrl":"https://xoomar.com/markets/stocks/mbx"},{"accessionNo":"0000315066-26-001256","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001776111","issuerName":"MBX BIOSCIENCES INC","ticker":"MBX","cusip":"55287L101","securityClass":"COMMON STOCK","eventDate":"2026-03-31","reportingPerson":"FMR LLC","reportingCik":null,"personType":"HC","sharesOwned":2936684,"percentOfClass":6.2,"filedAt":"2026-05-06","canonicalUrl":"https://xoomar.com/markets/stocks/mbx"},{"accessionNo":"0002012383-26-001704","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001776111","issuerName":"MBX BIOSCIENCES INC","ticker":"MBX","cusip":"55287L101","securityClass":"Common Stock","eventDate":"2026-03-31","reportingPerson":"BlackRock, Inc.","reportingCik":null,"personType":"HC","sharesOwned":2287497,"percentOfClass":4.8,"filedAt":"2026-04-27","canonicalUrl":"https://xoomar.com/markets/stocks/mbx"},{"accessionNo":"0000947871-26-000114","formType":"SCHEDULE 13D/A","amendmentNo":2,"issuerCik":"0001776111","issuerName":"MBX Biosciences, Inc.","ticker":"MBX","cusip":null,"securityClass":"COMMON STOCK","eventDate":"2026-02-05","reportingPerson":"ORBIMED ADVISORS LLC","reportingCik":"0001055951","personType":"IA","sharesOwned":3637887,"percentOfClass":7.7,"filedAt":"2026-02-11","canonicalUrl":"https://xoomar.com/markets/stocks/mbx"},{"accessionNo":"0000947871-26-000114","formType":"SCHEDULE 13D/A","amendmentNo":2,"issuerCik":"0001776111","issuerName":"MBX Biosciences, Inc.","ticker":"MBX","cusip":null,"securityClass":"COMMON STOCK","eventDate":"2026-02-05","reportingPerson":"ORBIMED CAPITAL GP VII LLC","reportingCik":"0001760648","personType":"OO","sharesOwned":2958000,"percentOfClass":6.3,"filedAt":"2026-02-11","canonicalUrl":"https://xoomar.com/markets/stocks/mbx"},{"accessionNo":"0000947871-26-000114","formType":"SCHEDULE 13D/A","amendmentNo":2,"issuerCik":"0001776111","issuerName":"MBX Biosciences, Inc.","ticker":"MBX","cusip":null,"securityClass":"COMMON STOCK","eventDate":"2026-02-05","reportingPerson":"OrbiMed Genesis GP LLC","reportingCik":"0001808744","personType":"OO","sharesOwned":679887,"percentOfClass":1.4,"filedAt":"2026-02-11","canonicalUrl":"https://xoomar.com/markets/stocks/mbx"},{"accessionNo":"0000902219-26-000071","formType":"SCHEDULE 13G/A","amendmentNo":4,"issuerCik":"0001776111","issuerName":"MBX Biosciences","ticker":"MBX","cusip":null,"securityClass":"Common Stock","eventDate":"2025-12-31","reportingPerson":"Wellington Investment Advisors Holdings LLP","reportingCik":null,"personType":"HC","sharesOwned":3349961,"percentOfClass":7.5,"filedAt":"2026-02-10","canonicalUrl":"https://xoomar.com/markets/stocks/mbx"},{"accessionNo":"0000902219-26-000071","formType":"SCHEDULE 13G/A","amendmentNo":4,"issuerCik":"0001776111","issuerName":"MBX Biosciences","ticker":"MBX","cusip":null,"securityClass":"Common Stock","eventDate":"2025-12-31","reportingPerson":"Wellington Management Group LLP","reportingCik":null,"personType":"HC","sharesOwned":3349961,"percentOfClass":7.5,"filedAt":"2026-02-10","canonicalUrl":"https://xoomar.com/markets/stocks/mbx"},{"accessionNo":"0000902219-26-000071","formType":"SCHEDULE 13G/A","amendmentNo":4,"issuerCik":"0001776111","issuerName":"MBX Biosciences","ticker":"MBX","cusip":null,"securityClass":"Common Stock","eventDate":"2025-12-31","reportingPerson":"Wellington Group Holdings LLP","reportingCik":null,"personType":"HC","sharesOwned":3349961,"percentOfClass":7.5,"filedAt":"2026-02-10","canonicalUrl":"https://xoomar.com/markets/stocks/mbx"},{"accessionNo":"0000902219-26-000071","formType":"SCHEDULE 13G/A","amendmentNo":4,"issuerCik":"0001776111","issuerName":"MBX Biosciences","ticker":"MBX","cusip":null,"securityClass":"Common Stock","eventDate":"2025-12-31","reportingPerson":"Wellington Management Company LLP","reportingCik":null,"personType":"IA","sharesOwned":3349961,"percentOfClass":7.3,"filedAt":"2026-02-10","canonicalUrl":"https://xoomar.com/markets/stocks/mbx"},{"accessionNo":"0002012383-26-000690","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001776111","issuerName":"MBX BIOSCIENCES INC","ticker":"MBX","cusip":null,"securityClass":"Common Stock","eventDate":"2025-12-31","reportingPerson":"BlackRock, Inc.","reportingCik":null,"personType":"HC","sharesOwned":2271161,"percentOfClass":5.1,"filedAt":"2026-01-21","canonicalUrl":"https://xoomar.com/markets/stocks/mbx"},{"accessionNo":"0001193125-25-282917","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001776111","issuerName":"MBX Biosciences, Inc.","ticker":"MBX","cusip":null,"securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2025-09-30","reportingPerson":"P. Kent Hawryluk","reportingCik":null,"personType":"IN","sharesOwned":1995759,"percentOfClass":4.3,"filedAt":"2025-11-14","canonicalUrl":"https://xoomar.com/markets/stocks/mbx"},{"accessionNo":"0001903360-25-000005","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001776111","issuerName":"MBX Biosciences","ticker":"MBX","cusip":null,"securityClass":"Common Stock","eventDate":"2025-09-30","reportingPerson":"Wellington Biomedical Innovation Master Investors (Cayman) II, L.P.","reportingCik":null,"personType":"PN","sharesOwned":2017394,"percentOfClass":4.5,"filedAt":"2025-11-12","canonicalUrl":"https://xoomar.com/markets/stocks/mbx"},{"accessionNo":"0001072613-25-000781","formType":"SCHEDULE 13D/A","amendmentNo":1,"issuerCik":"0001776111","issuerName":"MBX Biosciences, Inc.","ticker":"MBX","cusip":null,"securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2025-11-06","reportingPerson":"Rick Yang","reportingCik":"0001851328","personType":"IN","sharesOwned":3614486,"percentOfClass":8.1,"filedAt":"2025-11-10","canonicalUrl":"https://xoomar.com/markets/stocks/mbx"},{"accessionNo":"0001072613-25-000781","formType":"SCHEDULE 13D/A","amendmentNo":1,"issuerCik":"0001776111","issuerName":"MBX Biosciences, Inc.","ticker":"MBX","cusip":null,"securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2025-11-06","reportingPerson":"Mohamad H. Makhzoumi","reportingCik":"0001630226","personType":"IN","sharesOwned":3614486,"percentOfClass":8.1,"filedAt":"2025-11-10","canonicalUrl":"https://xoomar.com/markets/stocks/mbx"},{"accessionNo":"0001072613-25-000781","formType":"SCHEDULE 13D/A","amendmentNo":1,"issuerCik":"0001776111","issuerName":"MBX Biosciences, Inc.","ticker":"MBX","cusip":null,"securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2025-11-06","reportingPerson":"Edward T. Mathers","reportingCik":"0001328625","personType":"IN","sharesOwned":3619474,"percentOfClass":8.1,"filedAt":"2025-11-10","canonicalUrl":"https://xoomar.com/markets/stocks/mbx"},{"accessionNo":"0001072613-25-000781","formType":"SCHEDULE 13D/A","amendmentNo":1,"issuerCik":"0001776111","issuerName":"MBX Biosciences, Inc.","ticker":"MBX","cusip":null,"securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2025-11-06","reportingPerson":"Scott D. Sandell","reportingCik":"0001237289","personType":"IN","sharesOwned":3614486,"percentOfClass":8.1,"filedAt":"2025-11-10","canonicalUrl":"https://xoomar.com/markets/stocks/mbx"},{"accessionNo":"0001072613-25-000781","formType":"SCHEDULE 13D/A","amendmentNo":1,"issuerCik":"0001776111","issuerName":"MBX Biosciences, Inc.","ticker":"MBX","cusip":null,"securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2025-11-06","reportingPerson":"Paul Walker","reportingCik":"0001553150","personType":"IN","sharesOwned":3614486,"percentOfClass":8.1,"filedAt":"2025-11-10","canonicalUrl":"https://xoomar.com/markets/stocks/mbx"},{"accessionNo":"0001072613-25-000781","formType":"SCHEDULE 13D/A","amendmentNo":1,"issuerCik":"0001776111","issuerName":"MBX Biosciences, Inc.","ticker":"MBX","cusip":null,"securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2025-11-06","reportingPerson":"New Enterprise Associates 17, L.P.","reportingCik":"0001768564","personType":"PN","sharesOwned":3614486,"percentOfClass":8.1,"filedAt":"2025-11-10","canonicalUrl":"https://xoomar.com/markets/stocks/mbx"},{"accessionNo":"0001072613-25-000781","formType":"SCHEDULE 13D/A","amendmentNo":1,"issuerCik":"0001776111","issuerName":"MBX Biosciences, Inc.","ticker":"MBX","cusip":null,"securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2025-11-06","reportingPerson":"NEA Partners 17, L.P.","reportingCik":"0001796820","personType":"PN","sharesOwned":3614486,"percentOfClass":8.1,"filedAt":"2025-11-10","canonicalUrl":"https://xoomar.com/markets/stocks/mbx"},{"accessionNo":"0001072613-25-000781","formType":"SCHEDULE 13D/A","amendmentNo":1,"issuerCik":"0001776111","issuerName":"MBX Biosciences, Inc.","ticker":"MBX","cusip":null,"securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2025-11-06","reportingPerson":"NEA 17 GP, LLC","reportingCik":"0001796821","personType":"OO","sharesOwned":3614486,"percentOfClass":8.1,"filedAt":"2025-11-10","canonicalUrl":"https://xoomar.com/markets/stocks/mbx"},{"accessionNo":"0001072613-25-000781","formType":"SCHEDULE 13D/A","amendmentNo":1,"issuerCik":"0001776111","issuerName":"MBX Biosciences, Inc.","ticker":"MBX","cusip":null,"securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2025-11-06","reportingPerson":"Forest Baskett","reportingCik":"0001277631","personType":"IN","sharesOwned":3614486,"percentOfClass":8.1,"filedAt":"2025-11-10","canonicalUrl":"https://xoomar.com/markets/stocks/mbx"},{"accessionNo":"0001072613-25-000781","formType":"SCHEDULE 13D/A","amendmentNo":1,"issuerCik":"0001776111","issuerName":"MBX Biosciences, Inc.","ticker":"MBX","cusip":null,"securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2025-11-06","reportingPerson":"Ali Behbahani","reportingCik":"0001613867","personType":"IN","sharesOwned":3614486,"percentOfClass":8.1,"filedAt":"2025-11-10","canonicalUrl":"https://xoomar.com/markets/stocks/mbx"},{"accessionNo":"0001072613-25-000781","formType":"SCHEDULE 13D/A","amendmentNo":1,"issuerCik":"0001776111","issuerName":"MBX Biosciences, Inc.","ticker":"MBX","cusip":null,"securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2025-11-06","reportingPerson":"Carmen Chang","reportingCik":"0001746342","personType":"IN","sharesOwned":3614486,"percentOfClass":8.1,"filedAt":"2025-11-10","canonicalUrl":"https://xoomar.com/markets/stocks/mbx"},{"accessionNo":"0001072613-25-000781","formType":"SCHEDULE 13D/A","amendmentNo":1,"issuerCik":"0001776111","issuerName":"MBX Biosciences, Inc.","ticker":"MBX","cusip":null,"securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2025-11-06","reportingPerson":"Anthony A. Florence, Jr.","reportingCik":"0001559827","personType":"IN","sharesOwned":3614486,"percentOfClass":8.1,"filedAt":"2025-11-10","canonicalUrl":"https://xoomar.com/markets/stocks/mbx"},{"accessionNo":"0000902219-25-000364","formType":"SCHEDULE 13G/A","amendmentNo":3,"issuerCik":"0001776111","issuerName":"MBX Biosciences, Inc.","ticker":"MBX","cusip":null,"securityClass":"Common Stock","eventDate":"2025-09-30","reportingPerson":"Wellington Group Holdings LLP","reportingCik":null,"personType":"HC","sharesOwned":4823336,"percentOfClass":10.8,"filedAt":"2025-10-06","canonicalUrl":"https://xoomar.com/markets/stocks/mbx"},{"accessionNo":"0000902219-25-000364","formType":"SCHEDULE 13G/A","amendmentNo":3,"issuerCik":"0001776111","issuerName":"MBX Biosciences, Inc.","ticker":"MBX","cusip":null,"securityClass":"Common Stock","eventDate":"2025-09-30","reportingPerson":"Wellington Investment Advisors Holdings LLP","reportingCik":null,"personType":"HC","sharesOwned":4823336,"percentOfClass":10.8,"filedAt":"2025-10-06","canonicalUrl":"https://xoomar.com/markets/stocks/mbx"},{"accessionNo":"0000902219-25-000364","formType":"SCHEDULE 13G/A","amendmentNo":3,"issuerCik":"0001776111","issuerName":"MBX Biosciences, Inc.","ticker":"MBX","cusip":null,"securityClass":"Common Stock","eventDate":"2025-09-30","reportingPerson":"Wellington Management Group LLP","reportingCik":null,"personType":"HC","sharesOwned":4823336,"percentOfClass":10.8,"filedAt":"2025-10-06","canonicalUrl":"https://xoomar.com/markets/stocks/mbx"},{"accessionNo":"0000902219-25-000364","formType":"SCHEDULE 13G/A","amendmentNo":3,"issuerCik":"0001776111","issuerName":"MBX Biosciences, Inc.","ticker":"MBX","cusip":null,"securityClass":"Common Stock","eventDate":"2025-09-30","reportingPerson":"Wellington Management Company LLP","reportingCik":null,"personType":"IA","sharesOwned":4823336,"percentOfClass":10.6,"filedAt":"2025-10-06","canonicalUrl":"https://xoomar.com/markets/stocks/mbx"},{"accessionNo":"0001863769-25-000010","formType":"SCHEDULE 13D/A","amendmentNo":2,"issuerCik":"0001776111","issuerName":"MBX BIOSCIENCES, INC.","ticker":"MBX","cusip":null,"securityClass":"Common Stock, $0.0001 par value per share","eventDate":"2025-09-26","reportingPerson":"Frazier Life Sciences X, L.P.","reportingCik":"0001790879","personType":"PN","sharesOwned":5219440,"percentOfClass":11.7,"filedAt":"2025-09-30","canonicalUrl":"https://xoomar.com/markets/stocks/mbx"},{"accessionNo":"0001863769-25-000010","formType":"SCHEDULE 13D/A","amendmentNo":2,"issuerCik":"0001776111","issuerName":"MBX BIOSCIENCES, INC.","ticker":"MBX","cusip":null,"securityClass":"Common Stock, $0.0001 par value per share","eventDate":"2025-09-26","reportingPerson":"Patrick J. Heron","reportingCik":"0001365617","personType":"IN","sharesOwned":5224095,"percentOfClass":11.7,"filedAt":"2025-09-30","canonicalUrl":"https://xoomar.com/markets/stocks/mbx"},{"accessionNo":"0001863769-25-000010","formType":"SCHEDULE 13D/A","amendmentNo":2,"issuerCik":"0001776111","issuerName":"MBX BIOSCIENCES, INC.","ticker":"MBX","cusip":null,"securityClass":"Common Stock, $0.0001 par value per share","eventDate":"2025-09-26","reportingPerson":"FHMLS X, L.L.C.","reportingCik":"0001790811","personType":"OO","sharesOwned":5219440,"percentOfClass":11.7,"filedAt":"2025-09-30","canonicalUrl":"https://xoomar.com/markets/stocks/mbx"},{"accessionNo":"0001863769-25-000010","formType":"SCHEDULE 13D/A","amendmentNo":2,"issuerCik":"0001776111","issuerName":"MBX BIOSCIENCES, INC.","ticker":"MBX","cusip":null,"securityClass":"Common Stock, $0.0001 par value per share","eventDate":"2025-09-26","reportingPerson":"FHMLS X, L.P.","reportingCik":"0001790880","personType":"PN","sharesOwned":5219440,"percentOfClass":11.7,"filedAt":"2025-09-30","canonicalUrl":"https://xoomar.com/markets/stocks/mbx"},{"accessionNo":"0001863769-25-000010","formType":"SCHEDULE 13D/A","amendmentNo":2,"issuerCik":"0001776111","issuerName":"MBX BIOSCIENCES, INC.","ticker":"MBX","cusip":null,"securityClass":"Common Stock, $0.0001 par value per share","eventDate":"2025-09-26","reportingPerson":"James N. Topper","reportingCik":"0001341382","personType":"IN","sharesOwned":5219440,"percentOfClass":11.7,"filedAt":"2025-09-30","canonicalUrl":"https://xoomar.com/markets/stocks/mbx"},{"accessionNo":"0000947871-25-000872","formType":"SCHEDULE 13D/A","amendmentNo":1,"issuerCik":"0001776111","issuerName":"MBX Biosciences, Inc.","ticker":"MBX","cusip":null,"securityClass":"COMMON STOCK","eventDate":"2025-09-26","reportingPerson":"ORBIMED ADVISORS LLC","reportingCik":"0001055951","personType":"IA","sharesOwned":4002887,"percentOfClass":9,"filedAt":"2025-09-30","canonicalUrl":"https://xoomar.com/markets/stocks/mbx"},{"accessionNo":"0000947871-25-000872","formType":"SCHEDULE 13D/A","amendmentNo":1,"issuerCik":"0001776111","issuerName":"MBX Biosciences, Inc.","ticker":"MBX","cusip":null,"securityClass":"COMMON STOCK","eventDate":"2025-09-26","reportingPerson":"ORBIMED CAPITAL GP VII LLC","reportingCik":"0001760648","personType":"OO","sharesOwned":3255000,"percentOfClass":7.3,"filedAt":"2025-09-30","canonicalUrl":"https://xoomar.com/markets/stocks/mbx"},{"accessionNo":"0001876200-25-000004","formType":"SCHEDULE 13D/A","amendmentNo":1,"issuerCik":"0001776111","issuerName":"MBX BIOSCIENCES, INC.","ticker":"MBX","cusip":null,"securityClass":"Common Stock, $0.0001 par value per share","eventDate":"2025-09-26","reportingPerson":"Norwest Venture Partners XVI, LP","reportingCik":"0001876200","personType":"PN","sharesOwned":2136335,"percentOfClass":4.8,"filedAt":"2025-09-30","canonicalUrl":"https://xoomar.com/markets/stocks/mbx"},{"accessionNo":"0001876200-25-000004","formType":"SCHEDULE 13D/A","amendmentNo":1,"issuerCik":"0001776111","issuerName":"MBX BIOSCIENCES, INC.","ticker":"MBX","cusip":null,"securityClass":"Common Stock, $0.0001 par value per share","eventDate":"2025-09-26","reportingPerson":"NVP Associates, LLC","reportingCik":"0001545692","personType":"OO","sharesOwned":2136335,"percentOfClass":4.8,"filedAt":"2025-09-30","canonicalUrl":"https://xoomar.com/markets/stocks/mbx"},{"accessionNo":"0001876200-25-000004","formType":"SCHEDULE 13D/A","amendmentNo":1,"issuerCik":"0001776111","issuerName":"MBX BIOSCIENCES, INC.","ticker":"MBX","cusip":null,"securityClass":"Common Stock, $0.0001 par value per share","eventDate":"2025-09-26","reportingPerson":"Genesis VC Partners XVI, LLC","reportingCik":null,"personType":"OO","sharesOwned":2136335,"percentOfClass":4.8,"filedAt":"2025-09-30","canonicalUrl":"https://xoomar.com/markets/stocks/mbx"},{"accessionNo":"0001876200-25-000004","formType":"SCHEDULE 13D/A","amendmentNo":1,"issuerCik":"0001776111","issuerName":"MBX BIOSCIENCES, INC.","ticker":"MBX","cusip":null,"securityClass":"Common Stock, $0.0001 par value per share","eventDate":"2025-09-26","reportingPerson":"Tiba Aynechi","reportingCik":"0001669220","personType":"IN","sharesOwned":2140989,"percentOfClass":4.8,"filedAt":"2025-09-30","canonicalUrl":"https://xoomar.com/markets/stocks/mbx"},{"accessionNo":"0001876200-25-000004","formType":"SCHEDULE 13D/A","amendmentNo":1,"issuerCik":"0001776111","issuerName":"MBX BIOSCIENCES, INC.","ticker":"MBX","cusip":null,"securityClass":"Common Stock, $0.0001 par value per share","eventDate":"2025-09-26","reportingPerson":"Jon Erik Kossow","reportingCik":"0001726084","personType":"IN","sharesOwned":2136335,"percentOfClass":4.8,"filedAt":"2025-09-30","canonicalUrl":"https://xoomar.com/markets/stocks/mbx"},{"accessionNo":"0001876200-25-000004","formType":"SCHEDULE 13D/A","amendmentNo":1,"issuerCik":"0001776111","issuerName":"MBX BIOSCIENCES, INC.","ticker":"MBX","cusip":null,"securityClass":"Common Stock, $0.0001 par value per share","eventDate":"2025-09-26","reportingPerson":"Jeffrey Crowe","reportingCik":"0001535261","personType":"IN","sharesOwned":2136335,"percentOfClass":4.8,"filedAt":"2025-09-30","canonicalUrl":"https://xoomar.com/markets/stocks/mbx"},{"accessionNo":"0001863769-25-000010","formType":"SCHEDULE 13D/A","amendmentNo":2,"issuerCik":"0001776111","issuerName":"MBX BIOSCIENCES, INC.","ticker":"MBX","cusip":null,"securityClass":"Common Stock, $0.0001 par value per share","eventDate":"2025-09-26","reportingPerson":"FHMLSP, L.L.C.","reportingCik":"0001879465","personType":"OO","sharesOwned":1103920,"percentOfClass":2.5,"filedAt":"2025-09-30","canonicalUrl":"https://xoomar.com/markets/stocks/mbx"},{"accessionNo":"0001863769-25-000010","formType":"SCHEDULE 13D/A","amendmentNo":2,"issuerCik":"0001776111","issuerName":"MBX BIOSCIENCES, INC.","ticker":"MBX","cusip":null,"securityClass":"Common Stock, $0.0001 par value per share","eventDate":"2025-09-26","reportingPerson":"Frazier Life Sciences Public Fund, L.P.","reportingCik":"0001863769","personType":"PN","sharesOwned":1103920,"percentOfClass":2.5,"filedAt":"2025-09-30","canonicalUrl":"https://xoomar.com/markets/stocks/mbx"},{"accessionNo":"0001863769-25-000010","formType":"SCHEDULE 13D/A","amendmentNo":2,"issuerCik":"0001776111","issuerName":"MBX BIOSCIENCES, INC.","ticker":"MBX","cusip":null,"securityClass":"Common Stock, $0.0001 par value per share","eventDate":"2025-09-26","reportingPerson":"FHMLSP, L.P.","reportingCik":"0001879466","personType":"PN","sharesOwned":1103920,"percentOfClass":2.5,"filedAt":"2025-09-30","canonicalUrl":"https://xoomar.com/markets/stocks/mbx"},{"accessionNo":"0000947871-25-000872","formType":"SCHEDULE 13D/A","amendmentNo":1,"issuerCik":"0001776111","issuerName":"MBX Biosciences, Inc.","ticker":"MBX","cusip":null,"securityClass":"COMMON STOCK","eventDate":"2025-09-26","reportingPerson":"OrbiMed Genesis GP LLC","reportingCik":"0001808744","personType":"OO","sharesOwned":747887,"percentOfClass":1.7,"filedAt":"2025-09-30","canonicalUrl":"https://xoomar.com/markets/stocks/mbx"},{"accessionNo":"0001863769-25-000010","formType":"SCHEDULE 13D/A","amendmentNo":2,"issuerCik":"0001776111","issuerName":"MBX BIOSCIENCES, INC.","ticker":"MBX","cusip":null,"securityClass":"Common Stock, $0.0001 par value per share","eventDate":"2025-09-26","reportingPerson":"FHMLSP Overage, L.L.C.","reportingCik":"0001963248","personType":"OO","sharesOwned":325653,"percentOfClass":0.7,"filedAt":"2025-09-30","canonicalUrl":"https://xoomar.com/markets/stocks/mbx"},{"accessionNo":"0001863769-25-000010","formType":"SCHEDULE 13D/A","amendmentNo":2,"issuerCik":"0001776111","issuerName":"MBX BIOSCIENCES, INC.","ticker":"MBX","cusip":null,"securityClass":"Common Stock, $0.0001 par value per share","eventDate":"2025-09-26","reportingPerson":"FHMLSP Overage, L.P.","reportingCik":"0001963247","personType":"PN","sharesOwned":325653,"percentOfClass":0.7,"filedAt":"2025-09-30","canonicalUrl":"https://xoomar.com/markets/stocks/mbx"},{"accessionNo":"0001863769-25-000010","formType":"SCHEDULE 13D/A","amendmentNo":2,"issuerCik":"0001776111","issuerName":"MBX BIOSCIENCES, INC.","ticker":"MBX","cusip":null,"securityClass":"Common Stock, $0.0001 par value per share","eventDate":"2025-09-26","reportingPerson":"Frazier Life Sciences Public Overage Fund, L.P.","reportingCik":"0001913804","personType":"PN","sharesOwned":325653,"percentOfClass":0.7,"filedAt":"2025-09-30","canonicalUrl":"https://xoomar.com/markets/stocks/mbx"},{"accessionNo":"0001863769-25-000010","formType":"SCHEDULE 13D/A","amendmentNo":2,"issuerCik":"0001776111","issuerName":"MBX BIOSCIENCES, INC.","ticker":"MBX","cusip":null,"securityClass":"Common Stock, $0.0001 par value per share","eventDate":"2025-09-26","reportingPerson":"FHMLS XI, L.P.","reportingCik":"0001911580","personType":"PN","sharesOwned":3000,"percentOfClass":0,"filedAt":"2025-09-30","canonicalUrl":"https://xoomar.com/markets/stocks/mbx"},{"accessionNo":"0001863769-25-000010","formType":"SCHEDULE 13D/A","amendmentNo":2,"issuerCik":"0001776111","issuerName":"MBX BIOSCIENCES, INC.","ticker":"MBX","cusip":null,"securityClass":"Common Stock, $0.0001 par value per share","eventDate":"2025-09-26","reportingPerson":"FHMLS XI, L.L.C.","reportingCik":"0001911623","personType":"OO","sharesOwned":3000,"percentOfClass":0,"filedAt":"2025-09-30","canonicalUrl":"https://xoomar.com/markets/stocks/mbx"},{"accessionNo":"0001863769-25-000010","formType":"SCHEDULE 13D/A","amendmentNo":2,"issuerCik":"0001776111","issuerName":"MBX BIOSCIENCES, INC.","ticker":"MBX","cusip":null,"securityClass":"Common Stock, $0.0001 par value per share","eventDate":"2025-09-26","reportingPerson":"Frazier Life Sciences XI, L.P.","reportingCik":"0001911592","personType":"PN","sharesOwned":3000,"percentOfClass":0,"filedAt":"2025-09-30","canonicalUrl":"https://xoomar.com/markets/stocks/mbx"}],"updatedAt":"2026-11-05T12:42:36.499Z","source":"xoomar.com","docs":"https://xoomar.com/markets/api","license":"https://xoomar.com/terms","attribution":"Credit XOOMAR with a link to the dataset page on xoomar.com when you republish this data","canonicalUrl":"https://xoomar.com/markets/stocks/mbx","meta":{"source":"SEC","sourceAttribution":"Schedule 13D and 13G data: SEC.","notice":"10 requests a minute without a key, 30 with a free key. Get a free key at https://xoomar.com/signup?utm_source=api, register your app at https://xoomar.com/developers/register?utm_source=api, and credit the data as \"Data: XOOMAR\" together with the sourceAttribution line."}}